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Abstract
Osteoarthritis (OA) is a prevalent joint disease that results from the degradation of articular
cartilage, leading to inflammation, pain, and eventual joint failure. At one time, it was thought that
OA was only the result of the natural decline experienced in old age; however, various risk factors
have now been identified that may contribute to an increased risk for developing OA. Risk factors
may include joint loading, altered biomechanics, obesity, and joint injury, to which athletes are
exposed at a high rate. NFL athletes are one group of athletes that have continued to show a high
prevalence of arthritis in retirement, based on those risk factors. There is no current treatment
outside of anti-inflammatory medications and joint replacements, both of which do not always lead
to the most favorable outcomes. A high-fat, low carbohydrate diet, called the ketogenic diet, may
be able to prevent the onset of OA or treat it once it has developed. The ketogenic diet produces
ketone bodies which have been shown to decrease inflammation and reactive oxygen species, two
leading factors of OA development or potentiation. While research is not conclusive on how this
works, various studies have supported its claim. The following extended literature review aims to
determine if current research supports using the ketogenic diet in preventing or treating OA in NFL
athletes.
KEY WORDS: Osteoarthritis, ketogenic diet, NFL athletes, ketone bodies, joint loading
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1. Introduction
Disease, in all its forms, continues to afflict millions of people, threatening death and decreasing
quality of life. Researchers, physicians, scientists, and many more continue to fight and search for
treatments that could potentially cure any of the plethora of diseases that plague this world. Some
have prevailed while others have fallen short of this seemly impossible task. But what if the
treatment in many cases need not be found but refocused to areas of daily life? According to the
Centers for Disease Control, the four main factors for causing disease are tobacco use, poor
nutrition, lack of physical activity, and excessive alcohol use—all of which can be managed with
proper education and the initiative to make a positive change.1 In the crisis of disease, there is a
large emphasis on discovering new treatments or preventative measures to combat the
development of a disease, yet there are known manageable factors that prove to play a significant
role is disease pathology. Tobacco use, poor nutrition, lack of physical activity, and excessive
alcohol have proven to cause some of the most prevalent diseases such as liver disease, obesity,
diabetes, heart disease, and many others. And while it is easy for people to see how these factors
contribute to disease pathology, many people fail to recognize that the converse of these factors
can be used for good by preventing or treating disease. Eliminating tobacco use, limiting alcohol
use, participating in physical activity, and maintaining a balanced diet can play a role in healing
the body from disease or preventing it altogether. People have the power to influence their health
in a positive way, but effective education is a must for real change to occur. The following
literature review will attempt to do this by discussing osteoarthritis followed by proposing an
alternative, diet-based treatment.
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Osteoarthritis, simply defined by the Centers of Disease Control (CDC), is the morphological
change and damage that occurs to the ends of bones as a result of the breakdown of cartilage
between two bones of a joint.2 This creates pain, stiffness, and swelling that affects the daily
function of more than 32.5 million US adults, according to the CDC.2 While the disease symptoms
may be managed and some treatment may even stop further development of the disease, once
damage is done to the joint, it cannot be reversed.3 This places a greater emphasis on preventative
measures for osteoarthritis. Individuals with painful osteoarthritis symptoms may experience a
diminished quality of life through an inability to move in the same ways they once could. Those
diagnosed may not be able to participate in activities of daily living or recreational activities,
especially those that involve physical activity. In fact, some physical recreational activities can
create an increased risk for the development of osteoarthritis, as will be discussed in the following
review.

One group of individuals that have an increased risk for developing osteoarthritis are current or
retired National Football League (NFL) athletes. The force and stress exerted on the joints of NFL
athletes, a consequence of their sport, may damage the articular cartilage, thus increasing the risk
for developing osteoarthritis. As an athlete myself, I imagine the frustration a former NFL athlete
must experience when diagnosed with osteoarthritis, knowing their sport must have played a part.
I can also understand the disappointment an NFL athlete may feel when discovering they have
premature signs of osteoarthritis and must end their career for fear of further damage. Injuries, like
most all diseases, threaten to limit people and trap them into a specific outcome. And while some
treatments do exist for osteoarthritis, there are not many options that have shown positive results.
Additionally, there is no way to prevent the disease outside of proper body mechanics, exercise,
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and weight reduction. However, NFL athletes have teams of experts that monitor daily exercise,
biomechanics, and even nutrition, yet they are still a high-risk group. There must be a better way.

In the following literature review, finding a better way was the primary goal, and this was found
through the ketogenic diet. Through my research, I demonstrate that the ketogenic diet could
provide a positive avenue to treat the disease and potentially prevent the disease. While the
ketogenic diet has not been used in OA, it has been shown to benefit a plethora of other diseases.
Through research completed in similar areas, I was able to hypothesize the potential benefits in
osteoarthritis and provide another way for NFL athletes and all those diagnosed with osteoarthritis.
In the following literature review, I will discuss the research results that has led to this conclusion
followed by a hypothetical research proposal in this area of study.
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2. Methodology
The following thesis is an extended literature review constructed through reviewing current and
historical peer reviewed literature osteoarthritis, NFL athletes, and the ketogenic diet. The
information gathered was used to explain the disease pathology and characteristics of osteoarthritis
and provide a potential treatment alternative or preventative measure to high-risk populations.
Literature was then gathered in order to design a murine model experiment to test the hypothesized
treatment option and theorize what the experimental data would show from the hypothetical
experiment. This experiment was designed following historical and present murine model
experiments that involve osteoarthritis, ketogenic-like diets, and compression injuries. The data
was primarily collected through databases such as PubMed, PMC, and EBSCO host using search
terms such as ‘osteoarthritis,’ ‘osteoarthritis and compression injuries,’ ‘osteoarthritis and
football,’ ‘ketogenic diet,’ ‘ketogenic diet as treatment,’ and ‘inflammation.’ The sources were
found through journals such as American Journal of Sports Medicine, Science, Nature Medicine,
and Arthritis & Rheumatology.

5

3. Osteoarthritis
Osteoarthritis (OA) is a debilitating musculoskeletal disease that affects many people across the
globe. Statistically, it is the most prevalent joint disease, as well as the most prevalent type of
arthritis, affecting an estimated 10% of men and 18% of women over the age of 60 with a total of
242 million people with symptomatic OA worldwide.4,5 As a result of the various symptoms
associated with OA, people experience movement limitations creating difficulty in activities of
daily living (ADL) and regular exercise.5 These limitations greatly affect the holistic well-being
of the patient. For example, there is a 55% increase in mortality as a result of reduced physical
activity, comorbid conditions, and adverse effects to medications. 5 Additionally, it has been
determined that one-third of those diagnosed with OA that are over the age of 45 suffer from
depression or anxiety.6 Currently, the outlook is not grim as OA is the third most rapidly rising
condition associated with disability, behind diabetes and dementia.5 This creates a $136.8 billion
industry for OA related costs each year which made it the second most costly health condition
treated in hospitals in the United States in 2013.7,8 Despite continued research in OA treatment,
joint replacements still prevail as a leading way to inhibit the symptoms associated with OA.
Approximately 54% of people diagnosed with knee OA will undergo a knee replacement in their
lifetime.9 This is one large contributor to the economic burden associated with OA as joint
replacements can range from $30,000 to $112,000.10 The physical, mental, and economic burdens
associated with OA are supremely evident highlighting the need for research in this area.

OA is a disease of the joints that causes alterations in the composition, structure, and function of
articular cartilage resulting in changes to bone morphology. This change in morphology was once
considered to be the result of natural joint degeneration due to aging. This has since been disproven
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and it is now known to be the result of an imbalance in the biochemical mechanisms within a
joint.11 These biochemical mechanisms that result in morphological changes include, but are not
limited to, the following: degradation of articular cartilage, thickening of the subchondral bone,
osteophyte formation, synovial inflammation, degeneration of ligaments, hypertrophy of the joint
capsule, and changes in the muscles, nerves, and fat surrounding the joint. 12 Accompanying the
morphological changes are physical symptoms such as stiffness of the joint, pain, and eventual
joint failure.13 Typically, symptoms do not arise until the degeneration has reached its final stage
where it will be diagnosed as OA.13 In order to prevent joint failure, treatment research must
progress to find preventative measures and treatment options.

OA affects the joints of the body, but more specifically, it affects synovial joints. 14,15 Synovial
joints are characterized by a joint cavity encapsulated by a fibrous connective tissue called the
articular capsule, as shown in Figure 1.16 This joint capsule is filled with synovium, a thick, fluid
substance filled with synovial cells, in order to provide lubricant for bones to maintain healthy,
gliding movement.17 In addition to the synovium, the articular cartilage also aids in the smooth,
healthy joint movement. Articular cartilage is a thin layer of hyaline cartilage that covers the ends
of the articulating bones in order to protect and stabilize joints.14,16 Articular cartilage is a key
contributor to a healthy joint and is thus a key contributor to the development of OA when not
functioning properly. The articular cartilage is composed of a single cell type, chondrocytes, which
are then encased in the extracellular matrix (ECM) of collagen and proteoglycans.18 Collagen is
the main structural component of cartilage that supplies it with the tensile strength it needs. 17
Proteoglycans draw water into the joint to provide cushioning and support.18 Chondrocytes
produce and maintain the matrix by responding to changes in the joint in order to maintain
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homeostasis.18 These cells are usually quiescent and lack the ability to self-renew, making them a
prime target for detrimental effects leading to OA.19 Research has shown that chondrocyte death,
as a result of varying factors, is the main factor of OA development.19 This will be discussed further
in the following section.

Figure 1. A normal synovial joint that allows for smooth bending. The articular capsule contains
articular cartilage and synovial fluid for smooth movement while ligaments provide stability. 20

3.1 Pathophysiology
There is no one singular cause currently known for the development of OA but a plethora of factors
that contribute to the onset of joint destruction.20 These could include genetic predispositions,
aging, obesity, trauma, or other systemic diseases.21 Although the etiologies from patient to patient
may differ, the end-stage joint failure for each OA patient remains the same. The factors that result
in end-stage failure are complex and involve inflammatory, mechanical, and metabolic factors that
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prohibit the articular surface from properly functioning in distributing and absorbing mechanical
load of a joint.22 This ultimately leads to joint destruction and an OA diagnosis.

Chondrocytes are chiefly responsible for maintaining joint homeostasis through secretion of ECM
components in low turnover conditions. ECM receptors reside on chondrocytes that that allow the
cells to respond to stimulation, such as simple movement of the joint or weight placed on the
joint.18 This stress can be mostly inconsequential but act as a signal for the chondrocytes to
maintain homeostasis. However, chondrocytes do not always respond in the most beneficial way.
In the initial stages of OA development, chondrocytes respond harshly to various signals in a way
that leads to a cascade of events, ultimately resulting in a dysfunctional joint. These signals vary
depending on the patient and the predisposition at hand but some may include: high-magnitude
mechanical stress, excessive or abnormal joint loading, introduction of inflammatory cytokines,
reactive oxygen species, or injury to the surround cartilage or ligaments.23 In response to these
joint stimulators, chondrocytes and other cells in the synovium are activated and instead of
responding in a way that maintains homeostasis, catabolic effects ensue. This response by
chondrocytes may include upregulating synthetic activity, increasing production of inflammatory
cytokines, or producing matrix-degrading proteinases.18,23 As a result of this, proteoglycans and
the collagen network become depleted and chondrocytes undergo apoptosis from the lack of their
self-renewing capabilities.18

3.1.1 Inflammation
Inflammation is a cellular response to fight against infection in the body; however, in the case of
OA and other chronic disease such as neurological disease, obesity, cancer, and autoimmune
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disease, inflammation contributes to the development.24 The role inflammation plays in the
pathophysiology of OA is still unclear. It is still controversial whether inflammation is a primary
factor that acts as a stressor to begin cartilage degradation or if inflammation occurs as a result of
cartilage degradation.18 Some studies have shown that proinflammatory factors drive the
production of proteolytic enzymes that produce cartilage degradation seen in OA while other
studies have shown that chondrocytes produce proinflammatory factors in the absence of any other
inflammation.18,25 In either case, inflammation is a key contributor to the disease that consistently
appears in the synovial fluid of OA patients resulting in common OA symptoms such as pain,
swelling, and stiffness.18,26

Chondrocytes and synovial cells express what are known as pattern recognition receptors (PRR).27
PRR are part of the innate immune system and work as the first line of defense against invading
pathogens.27 They recognize damage-associated molecular patterns (DAMPs) and then respond
with pathways leading to a wide range of host defenses and inflammatory factors. PRR include
Toll-like receptors (TLR) and Nod-like receptors (NLR).27 Recent evidence shows that a wide
variety of endogenous products produced by cartilage matrix disruptions or cellular stress can bind
to TLRs or NLRs and activate their response, furthering the controversy between primary or
secondary inflammation.15 Following PRR activation, chondrocytes or synoviocytes, begin to
produce proinflammatory mediators, such as chemokines and cytokines.18 These are also a part of
the innate immune system and contribute to the development of OA by producing collagenases
and aggrecanases leading to ECM degradation.13 They also signal and arrange additional
inflammatory cells, including macrophages, granulocytes, and lymphocytes. 15 Other downstream
effects include the activation of NFκB, a protein complex that participates in cytokine production,
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and upregulation of nitric oxide via inducible nitric oxide synthase.18 A subset of Nod-like
receptors are NLR family pyrin domain containing 3 (NLRP3) inflammasomes, protein complexes
that activate inflammasomes leading to the activation of capase-1 and the cleavage of pro-IL-1β
and pro-IL-18 to their active form.27 NLRP3 inflammasomes have provided a central focus for OA
research as will be discussed below. PRR initiate and potentiate inflammatory responses that
induce catabolic action in chondrocytes, phenotypic shifts in the joint, and apoptosis of cells. 18
Repeated degradation of the articular cartilage coupled with constant inflammation results in
narrowing joint space and osteophyte formation leading to pain, stiffness, and the potentiation of
OA.14 This OA progression process is outlined in Figure 2 below.

Figure 2. Alterations in the joint environment may lead to inflammation-induced and stressinduced signaling pathways resulting in the production of chemokines, cytokines, adipokines, Tolllike receptor ligands, and nitric oxide. The result is an upregulation of ECM degradation products
leading to catabolic activity, phenotypic shifts, and apoptosis.18
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3.1.2 Reactive Oxygen Species
Another influential factor that may contribute to the development of OA is oxidative stress as a
result of reactive oxygen species. Reactive oxygen species (ROS) are free radicals that contain
oxygen including hydrogen peroxide, hydroxy radical, superoxide anion, and nitric oxide. 13 They
are compounds that contain an unpaired electron in their valence shell making them highly-reactive
and unstable in search of stability.28 The production of ROS are a part of normal physiological
processes that are needed for survival, such as O2- produced from electron transport chains in the
mitochondria, and pose no threat to the body at very low concentrations.19,28 However, when an
imbalance occurs, deleterious effects may ensue.

Oxidative stress is the result of an imbalance between ROS and their clearance through antioxidant
defense system. This imbalance has been shown to be a causative factor in many diseases, such as
Alzheimer’s, Parkinson’s, cardiovascular disease, and cancer.19,29,30 Oxidative stress has also been
concluded to be a leading contributor to OA development. This has been proven by examining
chondrocytes isolated from cartilage during end stage OA development and by finding lipid
peroxidation or nitrosylation in synovial fluid, such as in studies completed by Nemirovskiy et al.
in 2009 or Altay et al. in 2015.31,32 The exact pathway that oxidative stress uses to induce OA
development is still unclear.33 However, evidence has shown that oxidative stress, more broadly,
has a direct effect in chronic inflammation and redox signaling and control. 13,34 More specifically
in OA, research has shown that oxidative stress can regulate intracellular signaling that effects
chondrocyte apoptosis, extracellular matrix degradation, and disruption to the subchondral bone
in an interdependent relationship with inflammation. 19
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ROS may be produced in the mitochondria or peroxisomes, as well as any structure that contains
NADPH oxidases, Xanthine Oxidase, and Nitric Oxide synthases.35 Within the aerobic articular
cartilage, chondrocytes are host to numerous mitochondria where oxidative phosphorylation
occurs with subsequent production of ROS.36 One large contributor of ROS in OA development
are NADPH oxidases (NOX) expressed by chondrocytes.35 These are a family of seven enzymes
that respond to stimuli to complete a variety of functions, including host defense, cellular signaling,
and regulation of gene expression.37 They do so by transporting electrons to create redox signaling
and ROS generation.38 In OA development, NOX catalyze electron transfers from NADPH to
molecular oxygen, creating ROS.39 In addition, Nitric Oxide synthases (NOS) are another family
of enzymes that play a key role in ROS production in OA. NOS is available in three isoforms:
neuronal NOS, endothelial NOS, and inducible NOS.13 Inducible NOS are expressed by
chondrocytes and have been shown to be upregulated in OA cartilage, producing nitric oxide.13
Both NOX and inducible NOS contribute to an overproduction ROS making the antioxidant
system incapable of responding adequately.

NOX and inducible NOS are pathways that occur in a healthy body, as well as in a developing OA
patient. However, in OA patients, these pathways are upregulated to create a surplus of ROS
leading to oxidative stress. These pathways have various activating signals throughout the body
but in OA, their upregulation is dependent upon (1) inflammation and (2) mechanical stress. As
already discussed, inflammation is a large contributing factor to OA development with
inflammatory cytokines such as interleukin-1β, interleukin-17, tumor necrosis factor-α, interferonγ present in OA joints.40 In addition to their destructive effects on cartilage degradation, they also
act as signaling molecules for NOX and inducible NOS. Additionally, mechanical stress is a large
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factor for ROS development through these pathways. A study in 2007 on bovine articular cartilage
completed by Tomiyama et al. showed that mechanical compression greatly increased ROS.41
Another study in 2006 by Martin and Buckwalter showed that the introduction of antioxidant
treatment decreased cell death in vitro of human articular cartilage. 42 The ability of both
inflammation and mechanical stress to induce ROS in a joint is further facilitated by the cyclic
compression naturally found in a joint during movement.43 Free radical diffusion occurs
throughout all joint compartments and allows for the transfer of ROS during walking, running, or
daily activities.43 This may contribute to increases cartilage exposure to ROS.

ROS largely affect joints by enhancing the inflammatory process as shown above, but there are
also direct influences in OA progression. In general, research has shown that ROS directly
influence OA development by inciting cartilage degradation through expression of matrix
degrading proteases, inhibiting ECM synthesis, and inducing chondrocyte apoptosis, as outlined
in Figure 3 below.13 These is wide-ranging research currently available that shows the various
disruptions ROS can cause in the joint capsule and how it may contribute to OA development.
Altindag et al. in 2007 showed a positive correlation between oxidative stress and collagen
degradation, a major component of the ECM.44 Another study by Hashimoto et al. in 1998 showed
that increased levels of apoptotic cells had a positive correlation with increased levels of nitrogen
oxide production as OA progressed in rabbits.45 In addition to chondrocyte and collagen
degradation, ROS have also shown to have a role in preventing anabolic actions in the cartilage
matrix. H2O2 has been proven to prevent proteoglycan synthesis by suppressing oxidative
phosphorylation and adenosine triphosphate formation in chondrocytes.46,19 Subsequently, this
prevents the joint components from recovering following an event that induced cartilage injury.
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Other research has also shown that ROS decrease chondrocytes’ sensitivity to growth factors as
well as prevent chondrogenic precursor cells to enter an injured area by reducing capacity. 47,48
Additionally, research has found a notable alteration in mitochondria function in chondrocytes and
synovial cells in the presence of ROS which may be a leading cause of the factors outlined above.18
All of these factors influence the healthy functioning of a joint and present a key target for OA
treatment.

Figure 3. An increased level of reactive oxygen species leading to oxygen stress and its related
pathogenesis in OA.19

3.2 Risk Factors
Although OA is a degenerative disease, age is not the only risk factor and certainly not the
determining factor. The major risks can be divided into two main categories: natural predisposition
and joint biomechanics.14 Some individuals who develop OA exhibit natural predisposing factors
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shown to increase the likelihood of contracting the disease, but do not necessarily cause it. Age is
the strongest predisposing risk factor due to the body’s inability to regenerate cartilage over time,
as well as the accumulation of additional predisposing factors with time.17 Genetics is another
natural predisposing factor that has been researched, the results of which have identified that 11
loci can predispose OA, but it is not a strong enough factor to actually predict the onset of the
disease.17 Lastly, race can also be a natural predisposition with knee osteoarthritis occurring more
frequently in African Americans compared to Caucasians.14 None of these factors directly cause
the disease, but rather put a person at a higher risk for development.

Along with natural predisposition, joint biomechanics expose people to a variety of risks for
developing OA. Biomechanics that increase risk include injury, overload, and instability, which
can be caused by a variety of factors.14 Anatomical factors are a big risk to joint instability, as well
as overload and injury issues. Anatomical factors can include uneven leg length, poor muscle
strength, bone morphology, and many others.17 These factors can be the result of an injury or
naturally occurring. Although anatomical issues increase the likelihood of developing the disease,
it is not an indicator or cause of the disease. Injury, overload, and instability leading to
osteoarthritis is more prevalent in joints exhibiting anatomical issues compared to healthy joints,
but osteoarthritis still occurs in otherwise healthy joints. 17,14 Furthermore, injury can cause
structural issues in the joint that can lead to biomechanical risk factors, one instance of which is a
ligament or meniscus tear. Direct injury to a joint that causes damage to the bone or articular
cartilage can start the process of degradation and subsequent inflammation, pain, and stiffness that
occurs with OA.17 Additionally, obesity has been shown to be a large risk factor because it
increases the load on weight-bearing joints and produces inflammatory adipokines.17 Many of
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these factors are presented in a wide variety of populations, but some are affected by multiple
factors all at once.

3.2.1 Athletes at Risk
While the elderly population is at greatest risk for developing OA, young adults or even children
are not free of risk. Recreational and occupational activities pose a great risk to developing
osteoarthritis. In 2011, Cameron et al. found that active duty military personnel were shown to
have a significantly higher risk for OA compared to a general group of people of the same age.49
Another study in 2012 by Sulsky et al. found evidence to support job-related heavy lifting and
standing as a hazard to developing hip OA.50 Both of these provide evidence of physical load risk
factors for developing OA. There is large indication throughout the literature to suggest that
stressors applied to a joint through recreational or occupational activities often have detrimental
long-term effects and place a person at a much higher risk for developing OA.

Athletes increase their risk of OA with the participation in athletic activities. A systematic review
by Driban et al. in 2017 found that participants in long-distance running, wrestling, competitive
weightlifting, and soccer have a greater prevalence of knee OA. 51 Another study in 1996 by
Spector et al. saw a 2-3 fold increase in radiologic OA risks in the knees and hips of ex-elite female
athletes of weight-bearing sports.52 Research has even shown the effect of athletic activities
regardless of age or presumed healthy individuals. Rall et al. in 1964 found that 80% of American
football players who sustained a knee injury developed OA in the following 10 to 30 years.53
Loading and injury, due to the nature of many athletic events, are the main factors that contribute
to the increased risk of OA in athletes.
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Loading of joints, especially on the knees and hips, applies stress to the joint that must be
counteracted, by the work of the matrix, to sustain and protect the underlying bone. When force is
applied to a joint, fluid in the articular cartilage shifts to sustain the impact of the weight and
protect the bone from damage.14 However, this process does not occur quickly. Athletes who load
and unload joints in fast succession, do not give the fluid in the articular cartilage enough time to
move to provide compression and stability.14 The frequency at which most athletes participate in
athletic activities, as well as the intensity and speed used in most sports, applies stress to the
articular cartilage that is difficult for the joint to manage over long periods of time.

Direct, blunt injury to a joint can cause damage to the articular cartilage and eventually the whole
joint. Athletes are more likely to sustain an injury than the average person, and this injury can lead
to instability and deterioration of articular cartilage leading to the development of OA.14 In addition
to direct injury to a joint, injury to the surrounding muscles or ligaments puts the joint at risk. It
has been estimated that 50% of people diagnosed with ligament injuries, such as a meniscus tear,
will develop OA in the following 10 to 20 years.54 Luc et al. in 2014 determined that one third of
individuals that sustain an anterior cruciate ligament (ACL) rupture will develop OA in the
following 10 years.55 The stability and health of a joint depends on the whole musculoskeletal
system, which is often compromised when athletes sustain injuries in joint areas during athletic
participation.
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3.2.2 NFL Athletes at Risk
The individual risk factors associated with OA development accumulate as a result of athletic
participation leading to an overall higher risk for OA in athletes. This is true for athletes at any
level, but the degree and exposure of the risk factors are greatly heightened with professional
athletics. Athletes who earn their wage from participating in a sport dedicate years of their lives to
the sport at an extremely high level. Many professional athletes participate in their sport for 10+
years before even entering into a professional field. This means there are years and years of
running, lifting, kicking, hitting, throwing, etc. all on the same joints given at birth. As outlined
above, these events greatly influence the development of OA. The risk of damage associated with
professional athletics fluctuates depending on the sport itself, placing some professional athletes
in more need of alternative treatment options. NFL athletes are one of the highest at-risk
populations, making them a great target for continued research.

American football players continue to be a focus group for research in evaluating risk factors that
may lead to any possible short-term or long-term effects. Some risk factors that have been
associated with American football players may potentially lead to lasting effects on neurological,
musculoskeletal, and cardiovascular systems, as well as behavioral and mental health.56 Most
notably for this research, studied have determined that NFL athletes are at a large risk for
developing OA. Golightly et al. conducted a survey in 2009 with 2,538 retired NFL athletes and
reported that 40.6% of retirees under the age of 60 had been diagnosed with some form of
arthritis.57 This stands in great comparison to the 11.7% of U.S. males diagnosed in same age
group.57 While these risks continue to be highlighted in research and news alike, football
enthusiasts do not appear to be dissuaded from participation. In the 2017-2018 academic year,
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football had the largest number of participants in the NCAA with 73,557 athletes.58 While these
are not professional athletes, many of them are working at a very high level for an extended period.
For those possessing the athletic ability, football becomes a profession where their bodies are
exposed to various risk factors for many more years to come.

The exact reason for this increased risk is something that is still being studied and one that is
complex with many variables to consider. Some of the proposed factors have already been outlined
above, which include: joint loading, increased weight, and injury. These factors are extremely
prevalent in NFL athletes and often times lead to lasting and irreversible effects. One study by
Davies et al. in 2019 surveyed 2,432 retired NFL athletes with an average of 15.2 years of
participation in the NFL.59 11.4%, reported that they had a joint replacement with 7.7% reporting
knee replacements and 4.6% reporting hip replacements.59 Age, current weight, position, and each
additional knee or hip injury was also shown to increase the risk of replacement. Linemen showed
an 85% increase in hip replacement after retirement as compared to skill players. 59 Sustaining just
one knee injury increased the prevalence of knee replacement by 78% with each additional knee
or hip injury increasing the prevalence by almost twice that amount.59 This research clearly shows
the various and multi-dimensional factors that may contribute to the onset of OA in NFL athletes.

As outlined above, successive joint loading can cause an increased risk for developing OA.
Athletes who participate in sports that require quick joint loading create a risk to articular cartilage
by not providing enough time for joint fluids to counteract the blunt force being applied to a joint.14
Joint loading in NFL athletes is very common, especially for linemen. Linemen play from a
position known as the 3-point stance where they are squatting with one hand placed on the ground.
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Athletes in these positions explode out of their stance and into the opposing players. This explosive
position applies substantial force to the knee and hip joints.60 Additionally, joint loading could also
be a result of blunt trauma that occurs when helmets collide with joints, or minute trauma from
repetitive loading applied to the joint in a way that it cannot counteract.60,61

Obesity is another risk factor that may contribute to the increased prevalence of OA in NFL
athletes. It is known that obesity poses a risk for OA as it may produce inflammatory adipokines
or create an even greater joint loading risk to the athlete.17 In American football, weight gain is
often encouraged for linemen in order to succeed at their highly physical position.59 Maeda and
Moll determined that there was an average BMI of 36.0 for line players in the American Football
Conference in the NFL, indicating obesity, while other positions indicated a BMI between 27.9
and 37.1.62 These statistics certainly indicate a potential risk for the increased OA prevalence.
Additionally, research has shown a positive correlation between higher BMIs and prevalence of
injuries to joints, such as the ankles or knees.63 This leads to one of the greatest risk factors for OA
in NFL athletes.

Injuries to lower extremities, especially to the knees, is very common in American football. In the
same survey by Golightly et al., 52.8% of the retired NFL athletes reported knee injuries, 74.1%
reported ligament/tendon injuries, and 14.2% reported anterior cruciate ligament tears from their
time in the NFL.57 This is an astounding percentage of athletes that have sustained injuries. These
injuries are problematic for active players as these injuries may sideline athletes for an extended
period of time. But not only are they problematic in the moment, research also suggests that they
have lasting effects. Golightly et al. also determined that OA was more prevalent amongst those
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that had sustained a knee injury or a ligament/tendon injury with a 95% prevalence ratio in both
cases.57 This study suggests a large correlation between injury and OA development. When joint
areas are injured, the biomechanics of that joint are compromised. This could cause an altered and
damaging joint loading process leading to articular cartilage breakdown. Injuries themselves can
also start the degradation of the articular cartilage. In both these cases, over time, degradation of
the cartilage creates harmful effects leading to inflammation, ROS, and OA development.

3.3 Diagnosis
Diagnosis of OA is typically a combination of patient history, physical exam, diagnostic imaging,
and laboratory testing.14,64 Pain is the leading symptom described by OA patients.14 The pain may
be described as deep or aching that is worsened by movement or activity.64 At first, this pain can
be relieved by analgesics, but one’s body will eventually become unresponsive to medications.14,64
This pain is what ultimately pushes people to seek help and a diagnosis from physicians. Joint
stiffness, inflammation, crepitus, effusion, and decreased range of motion are other symptoms
described by OA patients.14,18,64 In majority of cases, symptoms only present once damage has
already occurred which cannot be reversed.

Radiographic imaging, magnetic resonance imaging (MRI), computed tomography (CT),
ultrasonography, and blood or urine tests are some ways physicians can confirm or deny an OA
diagnosis.64 Plain radiographic imaging is the most commonly used test to diagnose OA. Typical
findings for OA patients include joint space narrowing, osteophytes, subchondral bony sclerosis,
and cyst formation.14,64 Figure 4 below shows a radiographic image with signs of OA. MRI or CT
scans are used less often; but can still be used to determine if there are abnormalities. A CT scan
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may determine if there is a misalignment, while a MRI scan may be used to look for chondral
thinning, subchondral osseous changes, and osteophytes.64 Additionally, MRIs may also be used
to visualize articular cartilage or tissues supporting the joint, such as the meniscus or tendons, in
order to determine if there is a tear, which is a common predisposition to OA.64 Ultrasonography
is another tool that is used less often, but may be used to monitor cartilage degeneration. 64 Urine
and bloods tests are another way physicians can determine if there is a rise in effector molecules,
such as cytokines, or extracellular matrix components, such as collagen, which can be a
biochemical marker for OA.17 These options all provide results once degradation has begun but
there are not tests to show premature development, further emphasizing the importance of
preventative measures.

Figure 4. Radiographic image of an OA diagnosed knee. The arrow denotes medial joint space
narrowing.65

23
As stated previously, pain is the leading symptom associated with OA that often times pushes
patients to seek diagnostic help. People are usually not aware of the damage occurring in their
joints without evidence through pain. However, pain develops late in the stages of OA.17 By the
time a person is experiencing joint pain, the disease is often times advanced and irreversible.17
Pain is a subjective matter that varies across demographics with some individuals having higher
pain tolerances than others. It has been shown that pain tolerance decreases with age, which might
explain the prevalence of OA diagnoses in elderly populations.14 Additionally, athletes might
ignore pain by mistaking it for typical aches and pains associated with athletic competition.
Admitting to subtle aches or pains may risk a player’s opportunity to continue recreational or
occupational athletics. Early diagnosis or recognition of OA is pivotal in successful treatment.

3.4 Current Treatment
Treatment for OA depends on the severity and duration of the disease as well as the age of the
patients and desired goals after treatment. The main goal for any OA treatment is to alleviate
symptoms and improve functional status, which is especially important in athletes. 64 Treatments
for OA can be categorized by nonpharmacological, pharmacological, and surgical options. In any
case, treatment interventions that have few or no adverse effects must also be of low-risk to the
individual and proven to be effective for them to provide positive outcomes.17 In the following
sections, the current treatment options will be discussed.

Nonpharmacological options can include weight loss, physical activity, physical therapy,
modifications of activities of daily living (ADL), joint protection techniques, use of assistive
devices, bracing or taping joints, insoles, and much more.14,64 However, these options vary
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amongst demographics. Physical activity is a nonpharmacological treatment option that is still
being investigated. Uthman et al. completed a study in 2013 with 8,128 OA patients and concluded
that exercises that increase strength, flexibility, and aerobic capacity are likely to help treat OA.66
Physical activity is something that can cause the disease, as seen in NFL athletes, but can also be
used for benefit. In order for it be beneficial, specific regimens should be followed.

Another nonpharmacological form of treatment being investigated to slow the progression or
prevent the onset of OA is dietary changes. A study was done by the Osteoarthritis Initiative on
2,757 patients with knee osteoarthritis with a mean age of 62. 67 The study compared what they
called a traditional Western diet to what is known as a prudent diet.67 The Western diet relied
heavily on sugar-containing beverages, refined grains, desserts, processed meats, and French
fries.67 Conversely, the prudent diet consisted primarily of natural, unprocessed foods.67 OA
progression was monitored through radiographic imaging and measured by the Kellgren-Lawrence
(KL) scale, loss in joint space width (JSW), and symptomatic progression by the Western Ontario
and McMaster Universities Arthritis index (WOMAC). 67 The study found that the Western diet
increased KL-worsening risk and increased odds of a higher WOMAC score.67 In contrast, the
prudent diet showed a decreased KL-worsening risk, decreased JSW loss, and decreased odds of
higher WOMAC progression.67 This is just one example of how diet can positively influence the
progression of OA.

There has also been evidence of beneficial results for pharmacological options in OA patients.
Pharmacological options primarily include the use of acetaminophen and non-steroidal antiinflammatory drugs (NSAIDs) to alleviate pain and reduce inflammation. 64 Steroid injections, such
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as corticosteroids, may also be used in the joint for its anti-inflammatory effect.64 However,
corticosteroids must be used with caution because of the cytotoxicity of steroids to chondrocytes.17
These are primarily options to prevent pain and enhance one’s quality of life. Other drug options
have been found to show some disease treatment properties. For example, chondroitin and
glucosamine have shown to be effective for its anti-inflammatory and anticatabolic effects on the
joint cartilage.17 Pharmacological options for pain and symptom relief are extremely prevalent but
options for the prevention or treatment still require much additional research.

Surgery is another option for OA patients, and can include options such as articular cartilage
transplant, regeneration stimulations, and joint replacement.17 Surgery is typically not a preferred
option for most patients, especially current athletes, due to the risks and recovery factors of
surgery. Joint replacement has shown to provide poor functional outcomes, as well as short life
span of the protheses.61 In any case, the ultimate goal of treatment is to provide symptom relief
and functional freedom with the lowest risk possible to the patient. This is a difficult task to achieve
as many treatment options for any disease have at least some small risk. This is not necessarily the
case for more natural options as will be discussed in the following section.
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4. Ketogenic Diet
The ketogenic diet (KD) consists of eating high fats, moderate proteins, and low carbohydrates in
order to put the body in a state of ketosis.68 The ratio of fats to carbohydrates and protein of a
classic KD consists of 3-4:1. There are many variations of the classic KD depending on the ratio
which may include: the Modified Ketogenic Diet (2:1), the Modified Atkins Diet (1:1), and the
Medium-Chain Triglyceride Oil Diet (1.9:1).69 These diets work to limit carbohydrates, or sugars,
which are the primary source of energy in the body and the easiest source for the body to access.70
When the body is deprived of carbohydrates, the body enters a catabolic state where it will use its
glycogen stores.70 Once glycogen stores are depleted, the body enters gluconeogenesis, a state
where the liver produces glucose primarily from lactic acid, glycerol, and the amino acids alanine
and glutamine.70 This, however, is not sustainable for long periods of time so the body must find
another source of energy. This is when the body enters ketogenesis, a process where fatty acids
stored in the body are metabolized to acetoacetate and beta-hydroxybutyrate.70 Acetoacetate and
β-hydroxybutyrate are the two main forms of ketone bodies in which the body uses for energy
when glucose levels are depleted.68 This process maintains homeostasis when the body is
experiencing a caloric restriction but in the case of the ketogenic diet, glucose restriction activates
it.68 The production of ketone bodies and their effect are the hypothesized reasoning for the benefits
seen when using the ketogenic diet.

The KD first emerged in the 20th century in the United States and France as a treatment form for
epilepsy.71 In 1920, Dr. Stanley Cobb and Dr. William Lennox determined that starvation had a
positive effect on seizure control.71 It was during this same period that Dr. RT Woodyatt at Rush
Medical College identified the production of ketone bodies as a result of fasting. 71 He then
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replicated these results with a high fat, low carbohydrate diet. It was through these findings that
Dr. Russel Wilder at Mayo Clinic suggested a high fat, low carbohydrate diet be used for children
suffering from epilepsy and termed it the ketogenic diet.72 Since then, the KD has been shown to
be effective in treating many other conditions. Research has shown that the KD can be effective in
improving blood pressure, blood glucose, triglycerides, and HDL cholesterol levels. 70
Additionally, it may be effective in treating ischemic strokes, Parkinson’s disease, Alzheimer’s
disease, sleep disorders, cancers, autism, amyotrophic lateral sclerosis, and many others. 71,73 Many
of these improvements can be attributed to an enhanced neuro functioning as seen in research. One
study in 2019 by Fortier et al. showed a 230% increase in brain ketone metabolism on a high fat
diet and subsequently the subjects’ episodic memory, language, executive function, and processing
speed improved compared to baseline.74 Another study by Appelberg et al. in 2009 reported that
traumatic brain injury induced rats fed a KD improved more than those fed a regular diet.75
Research using the KD continues to divulge into a variety of conditions as more is being discovered
on the benefit of ketone bodies.

4.2 Ketone Bodies
The body is continuously producing small amounts of ketone bodies for energy, with each
producing 22 ATP under normal circumstances.76 These have provided mammalian energy for a
variety of physiological states including starvation, the neonatal period, post-exercise, pregnancy,
and low carbohydrate diets such as the KD.73 In a typically healthy adult, there is approximately
100-250 μM ketone bodies in circulation.73 This rises steadily in any of the physiological
conditions listed above. After prolonged exercise or 24 hours of fasting, the circulation of ketone
bodies may reach 1 mM.73 In pathological states, such as diabetic ketoacidosis, this may rise as
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high as 20 mM.73 However, this pathological state seen in type 1 diabetics is not achievable by
diet alone.69 For the KD, optimal levels of 2 mM are consistently maintained when carbohydrates
are avoided.76 There is the possibility for minimal adverse events in this state such as
gastrointestinal symptoms, weight loss, headaches, and fatigue but these symptoms typically
resolve after a few weeks on the KD.69

Ketone bodies are water-soluble lipid molecules with two R-groups attached to a carbonyl group.76
Ketogenesis is the process in which they are formed by the breakdown of fatty acids, the rate of
which is proportional to total fat oxidation.73 Approximately 80% of the stored energy in the human
body is in the form of fatty acids contained in adipose tissue.77 During periods of fasting or
carbohydrate depletion, these fatty acids are mobilized from adipocytes to the liver where they are
converted to ketone bodies.77 Once formed, ketone bodies are transferred to other tissues where
they are metabolized into acetyl-CoA and eventual ATP for energy.77 Regulators of this
metabolism is extensive and still not completely understood.

Ketone body production begins when fatty acids are brought into the mitochondria via carnitine
palmitoyl transferase (CPT-1) and the acyl chains are transported through the mitochondrial
membrane and undergo β-oxidation.73 In the fate committing state, 3-hydroxymethylglutaryl-CoA
synthase (HMGCS2) catalyzes acetoacetyl-CoA (AcAc-CoA) and acetyl-CoA to generate 3hydroxymethylglutaryl-CoA (HMG-CoA), as shown in Figure 5 below.73 HMG-CoA lyase
(HMGCL) then cleaves HMG-CoA to release acetyl-CoA and acetoacetate (AcAc).73 AcAc is then
reduced in the final step to the ketone body, D-β-hydroxybutyrate (D-βOHB) by
phosphatidylcholine-dependent mitochondrial D-βOHB dehydrogenase (BDH1) in a near-
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equilibrium reaction with NAD+/NADH.78 AcAc can also be converted to another ketone body,
acetone, through a non-enzymatic decarboxylation.76 Once production is complete, ketone bodies
are transported out of the liver via monocarboxylate transporters (MCT1 and MCT2) into
circulation for terminal oxidation in extrahepatic tissues.73 The exact mechanism for transport is
not currently known, but research has shown a higher concentration of circulating ketones as
compared to extrahepatic tissue concentrations which suggests that ketone bodies move down a
concentration gradient.73 Acetone, however, is only excreted through urine or exhaled because it
does not have the capabilities for terminal oxidation.76 This has caused research to focus primarily
on the work of β-hydroxybutyrate in the body.

Once transported outside of the liver, β-hydroxybutyrate must be catabolized in the mitochondria
of extrahepatic tissues to acetyl-CoA to be made available for the citric acid cycle (TCA) for
terminal oxidation.73 This is then used for energy in the body during carbohydrate depletion. First,
mitochondrial BDH1 catalyzes a reaction to oxidize βOHB in order to convert it back to AcAc.73
AcAc is activated to AcAc-CoA when succinyl-CoA exchanges a CoA-moiety.73 This reaction is
catalyzed by succinyl-CoA:3-oxoacid-CoA transferase (SCOT) in a near-equilibrium reaction.73
The energy released from hydrolysis of AcAc-CoA is greater than the release from succinyl-CoA
which permits the reaction to favor AcAc formation. 73 Next, any of the four mitochondrial
thiolases catalyzes a reaction to convert AcAc-CoA to two molecules of Acetyl-CoA.73 These
molecules then enter the TCA cycle where they are oxidized to later form ATP. It is also important
to note that no ATP is used to activate ketone bodies, while glucose and direct fatty acids do require
the investment of ATP.73
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Figure 5. Ketogenesis occurs in the hepatic mitochondria starting from Acyl-CoA and ending with
Acetone, Acetoacetate, or β-hydroxybutyrate. HMGCS2 is the fate committing step that allows for
ketone production after which they are transported to extrahepatic tissues. They then undergo
reactions that require the fate committing step of SCOT and are terminally oxidized for energy
use. There is still uncertainty for the mechanism of transfer, as indicated by the question marks.73

Ketone body metabolism provides efficient and effective energy but that is certainly not its only
role. Continued research in ketogenesis has shown that β-hydroxybutyrate is not only an energy
carrier but plays a direct and indirect role is signaling that may affect gene expression, lipid
metabolism, neuronal function, and metabolic rate.77 β-hydroxybutyrate has been shown to have
direct effects on the body through cell-surface receptors, competitive inhibition of enzymes,
protein posttranslational modification, and modulation of ion channels.77 These signaling
functions’ reduction effect on inflammation and oxidative stress has continued to be revealed
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through research. This reduction provides a positive potential for an alternative treatment option
in OA.

4.3 Anti-Inflammatory
The inhibition of glycolysis, or the breakdown of sugar by the body for energy, is known to dampen
the body’s pro-inflammatory responses, making ketone metabolism an interesting point of research
for OA treatment.27 Currently, research has suggested a role of ketone body metabolism in the
regulation of the innate immune system.79 This has made starvation states and the KD a prevalent
area of research as this could be a way to treat multiple diseases that have a pro-inflammatory
aspect, such as atherosclerosis, asthma, inflammatory bowel disease, arthritis, and many more.73
In a study conducted in 2008 by Forsythe et al., 40 overweight subjects were fed either a very low
in carbohydrate diet or an isocaloric diet for 12 weeks.80 The results showed that both were
associated with a decrease in several serum inflammatory markers; however, there was a greater
anti-inflammatory effect with the KD, indicating a future research focus for ketone bodies and
inflammation.80 Despite growing research, the exact role of ketone bodies in the innate immune
system is still not known. However, there are multiple proposed mechanisms for action, two of
which will be discussed below.

4.3.1 GPR109A
Ketone bodies have been shown to have a signaling effect through G-protein coupled receptors
through unclear mechanisms. One G-protein coupled receptor that ketone bodies have been shown
to effect are GPR109A, also known as HCA2 or NIACR1.73 These receptors are bound and
activated by the ketone, β-hydroxybutyrate.77 Currently, β-hydroxybutyrate is the only known
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endogenous ligand for the receptor.81 This receptor is expressed in many cell types, including
immune cells such as macrophages and monocytes, microglia, and colonic epithelial cells. 73 In
these cells, the receptor’s activation leads to anti-inflammatory effects as a result of the activation
of intracellular calcium release, prostaglandin alterations, and downstream inhibition of NF-κB.77
NF-κB is a transcription factor that is considered to be a master regulator of the innate immune
system, leading to pro-inflammatory responses of the body.82 When GPR109A is activated,
research suggests that it induces a macrophage phenotype related to prostaglandin D2 (PGD2) that
works to resolve inflammation.83 Additionally, research by Zandi-Nejad et al. in 2013, suggests
that a metabolite of PGD2, known as IKB kinase, works as an inhibitor of NF-κB in macrophages
leading to a decrease in the production of inflammation.84 Another study by Fu et al. in 2014
similarly showed a decrease in proinflammatory enzymes and proinflammatory cytokines as a
result of the inhibition of NF-κB from β-hydroxybutyrate.85 The exact mechanism requires further
research but these results provide substantial evidence for the work of β-hydroxybutyrate.

4.3.2 NLRP3 Inflammasome
The most prevalent area of research in regards to decreased inflammation as a result of βhydroxybutyrate is the NLRP3 inflammasome. The NLRP3 inflammasome is a multi-protein
complex sensor in the innate immune system that responds to damage in the body by activating
capase-1 which promotes secretion of pro-inflammatory cytokines IL-1β and IL-18 in
machrophages.79,86 Removal of this inflammasome has shown to improve other diseases such as
diabetes, bone loss, gout, Alzheimer’s, age-related functional decline, atherosclerosis, and multiple
sclerosis.79 Research by Youm et al. in 2015 was the first to recognize the direct role that ketones
played in limiting the NLRP3 inflammasome.79 Prior to this, studies had shown that there was a
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link between circulating ketones and the regulation of the inflammasome, but these studies
suggested that it was a result of the reduced oxidative stress, increased adenosine monophosphateactivated protein kinase (AMPK), or autophagy.79,87,88,89 Youm et al. determined that it was not
the case.

In that same study by Youm et al. in 2015, macrophages derived from lipopolysaccharide-primed
bone marrow of mice were treated with ATP, an NLRP3 activator, and two ketone bodies: βhydroxybutyrate and acetoacetate.79 β-hydroxybutyrate was shown to dose-dependently inhibit
ATP-induced capase-1 cleavage and the processing of IL-1β, while AcAc was shown to be
inconsequential.79 The study also found that β-hydroxybutyrate acted on five other NLRP3
activators to prevent inflammation.79 The results were determined to not be dependent on
starvation regulated mechanisms like AMPK, ROS, or autophagy but on the ketones themselves. 79
The research concluded that β-hydroxybutyrate controls an unknown event that results in a
reduction in K+ efflux from macrophages, inhibition of ASC oligomerization and an inability for
the assembly of the inflammasome. As a result of all of this, inflammation is decreased. This study
provided substantial evidence to suggest that the ketogenic diet could positively affect the
development of OA and a potential for furthered research with NLRP3 inflammasomes.

4.4 Reduced Oxidative Stress
Mitochondria are the powerhouse of the cell as this is where ATP is produced through oxidative
phosphorylation. It is through this process that ROS are produced through the escape of electrons
during transfer along the electron transport chain leading to oxidative stress, damaging the
mitochondria in a positive feedback loop.69 This increase in ROS and subsequent damage to the
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mitochondria is decreased in ketone body metabolism as compared to glycolysis.90 This reduction
is due, in part, to the uncoupling proteins that are expressed during ketone metabolism.91 These
proteins lead to a reduced mitochondria potential, followed by a decrease in the ROS produced. 91
This alone provides a large benefit for one’s general health, but it also has the potential to provide
a large benefit for those at risk for developing OA or those already diagnosed with OA. Decreased
ROS by this means is just one factor that has been shown to be affected by ketones, while many
more theories of their benefit exist.

4.4.1 Nrf2
One of the primary ways that ketone bodies affect and reduce oxidative stress is through the
activation of the nuclear factor erythroid-derived 2 (NF-E2)-related factor 2 (Nrf2).69 This is a
transcription factor that belongs to the cap “n” collar subfamily of basic-region leucine zipper
transcription factor.92,93 Nrf2 has been shown to be the central protein that interacts with a common
DNA sequence, called the antioxidant response element, to activate gene transcription in response
to rising oxidative stress.93,94 This response mediates drug-metabolizing enzymes leading to
elimination of exogenous and endogenous chemicals that lead to oxidative stress.93 Research by
Talalay et al. in 2003 showed that an increase in Nrf2 activity in mice through chemoprotective
agents was associated with protection from oxidative stress.95 Other research continues to support
this claim.

Although research has continually supported the notion that β-hydroxybutyrate activates Nrf2, the
mechanism by which it occurs is still not understood.69 Milder et al. in 2010 showed that in the
mitochondrion of the hippocampus of rats fed a KD, an initial increase in ROS occurred after only
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1 day followed by a large reduction after 3 weeks of the diet.96 Based on these results, Pinto et al.
in 2018 hypothesized that the initial increase in H2O2 provided a redox signal for βhydroxybutyrate to do its work.69 Additionally, the initial increase in H2O2 may enhance the
binding of Nrf2 to the antioxidant response element, as indicated in a study by Wilson et al. in
2005.97

4.4.2 HDAC
Another potential area of study that has shown to be influenced positivity by ketone bodies are
histone deacetylases (HDAC). HDAC are nuclear proteins that consist of a deacetylase domain
that typically work in large regulatory multiprotein complexes.77 They function to suppress gene
expression through deacetylating DNA, thus creating tightly condensed chromatin that cannot be
transcribed.98 β-hydroxybutyrate works to prevent this by competitively inhibiting HDACs. As a
result, the transcription of genes that detoxify ROS can be upregulated. These include catalase,
mitochondrial superoxide dismutase and metallothionein 2.69 One study completed in 2020 by Solé
et al. showed that β-hydroxybutyrate worked to slow the progress of OA in vitro and in vivo as a
result of HDAC inhibition.76 Another study by Shimazu et al. in 2013 showed similar results in
mouse tissue treated with β-hydroxybutyrate.87 The study showed that there was an increase in
histone acetylation of the Foxo3a and Mt2 promoters and both of the genes were activated because
of the selective depletion of HDACs.87 This led to an increased protection from oxidative stress.87
This research provides substantial evidence to suggest a potential for using the KD as a
preventative measure or treatment option for OA.
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5. Research Proposal
In light of the information gleaned from numerous completed studies, it is apparent that there is a
need for alternative preventative measures or treatment options for those at risk for developing
OA. Research shows that OA contributes to pain and decreased mobility, as well as mental and
emotional struggles. For those that are diagnosed, it is a devastating reality to know that there is
no way to stop continued bone breakdown. They have two options, anti-inflammatory medications
once symptoms present or joint replacement once the joint has failed. Anti-inflammatory
medications seem to only treat the pain but do little to stop the progression of the disease. Joint
replacement is often very costly and is typically only an option at the end of disease development.
There needs to be additional therapies.

There are many at risk for developing OA. These may include individuals with occupational
hazards, increased age, certain genes, musculoskeletal trauma, obesity, and increased physical
activity. While there are many populations of people that fit into these categories, NFL athletes
continue to be a population that fit into many of these categories, not just one. That is why this
research aims to focus on providing a preventative measure or treatment option for OA in NFL
athletes. While there are currently no ways of perfectly predicting who will develop OA, there are
a large number of factors that can be identified for those that are at higher risk, NFL athletes being
one of those. With this in mind, a preventative measure would allow the significant number of
NFL athletes who are diagnosed with OA to decrease. For those that choose not to partake in a
preventative option, there needs to be a way to treat those that become diagnosed with OA later in
life.
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The ketogenic diet has existed since 1920; however, there are still a lot of unanswered questions
for how it produces the effects it does on the body. While this research study does not aim to
answer those questions, it does aim to determine how it may help to treat or prevent OA in highrisk groups. Though there are many unanswered questions, research does continually support the
claim that it reduces oxidative stress and limits inflammation, two things that are key to OA
development. Other studies conducted have shown a decrease in OA biomarkers using the
ketogenic diet, but there are no current studies aimed at targeting NFL athletes specifically.
Additionally, research has not been able to determine if OA begins by oxidative stress and
inflammation or if they are only potentiators of the disease. Because of this, a research study would
need to be conducted that tests the potential for the KD being used as a preventative measure and
a treatment option in NFL athletes. In order to fully examine the ketogenic diet’s effect on joint
health, a model would need to be used to mimic what is seen in NFL athletes.

5.1 Research Model
The objective of this proposed research is to determine the potential benefits of the KD in
preventing or treating OA in NFL athletes. Because the joint will need to be examined for specific
markers of degeneration and inflammation, the research is designed to be carried out in an
osteoarthritic mouse model. While this model will not perfectly represent the various factors that
contribute to OA in NFL athletes, this study would provide preliminary testing to determine if
further research should be conducted specifically with NFL athletes and the KD. This research
study will also provide results for areas outside of NFL athletes. There are many OA high-risk
groups that may benefit from the unique properties of the KD. This research specifically aims to
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determine if the KD can prevent or treat osteoarthritis in C57B/6J mice that will resemble the joint
loading representative of that seen in NFL athletes.

5.1.1 Mouse Model
The mouse model will consist of forty-eight C57B/6J mice that are at least 10 weeks old. At that
age, the mice have developed enough that they are able to manage joint damage that would be
representative of an adult human’s ability.99 Male gender is also important in the representative
model as research has shown that OA is more prevalent in females and hormonal causes may
contribute to their decreased ability to maintain joint health.99 It will also need to be ensured that
the mouse model does not have any genetic predispositions for developing OA. This will allow for
a proper analysis of the effects of the KD on OA in NFL athletes without variance from genetic
dispositions.

All of the mice will be treated appropriately, according to the Public Health Service’s Policy on
Humane Care and Use of Laboratory Animals. Each of the mice will be held in separate, ventilated
cages where they will have 12-hour cycles of light and dark. Food will be provided to them either
in the form of the KD or the regular chow diet. The mice fed a KD will be fed at specific intervals
in order to monitor the daily macronutrient levels. The control groups will be fed a regular chow
ad libitum. The regular chow diet will be composed of agricultural byproducts, such as corn, oats,
wheat, alfalfa, and a protein source, as well as supplemented with vitamins and minerals. 100 The
ketogenic diet will consist of casein, cornstarch, sucrose, soybean oil or lard, and supplemented
with vitamins and minerals.100 This will be given to the test group animals in ratios of 8:1:1 for
fat, protein, and carbohydrates, respectively. This allows the mice to enter a state of ketogenesis
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where the body is relying on fatty acid breakdown and subsequent ketone bodies for energy, rather
than the typical glucose stores.

5.1.2 Ketosis Monitoring
During the research conduction, it will be critical that the ketone body levels are monitored
consistently. In order to do this, the Precision Xceed Pro Point of Care System will be used. This
is a machine that is designed to determine blood ketone levels. 101 This requires puncturing the
surface of the animal to draw blood out which will then be placed on the test strips. The reading
will determine if the animal has entered ketosis or not. Ketosis is defined as having a steady ketone
body composition of at least 2 millimole/L.76 This will be used as the standard for determining
ketosis in the mouse model.

5.1.3 Osteoarthritis Induction
In order for this study to adequately represent OA development that is seen in NFL athletes, it
must be induced in a similar manner. However, there are many factors that contribute to their highrisk identification in NFL athletes with no research definitively pointing to a direct cause in every
instance. Additionally, research has found that different positions on the team take on a different
level of risk. Research has determined that joint loading does play a significant part in developing
osteoarthritis. While this may not be the only cause, it will provide a similar factor to mimic what
is seen in NFL athletes. In order to induce OA in the mouse model that mimics joint loading, an
Intron Electro Pulse E1000 will be used. This is an instrument designed to test dynamic and static
force for a variety of materials. Wu et al. conducted a study on a mouse model in 2015 using this
machine.102 The study aimed to determine what force load and cycle length most closely mimicked
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the joint loading effects known to induce OA. The research conducted by Wu et al. determined
that 6 Newtons of force for 60 cycles induced OA as evidenced by chondrocyte apoptosis, cartilage
matrix degradation, disruption of cartilage collagen fibril arrangement, and increased levels of
serum cartilage oligomeric matrix protein.102 Based on those results, the mice in this study will
also be subjected to 60 cycles of 6 Newton joint force to the knee. The knees will be placed hyper
flexed in the Intron Electro Pulse E1000, as shown in Figure 6 below. The mice will also be sedated
under anesthesia to ensure proper treatment.

Figure 6. The Intron Electro Pulse E1000 that will be used to induce OA in the mouse model. 102

5.1.4 Osteoarthritis Testing
During the study, the progress, or lack thereof, of OA will be consistently monitored. This will
occur during the duration of the study by noninvasive means. At the conclusion of the study, the
animals will be sacrificed so that histological studies can be conducted on the joint to more
adequately determine the efficacy of the KD. While the study is ongoing, inflammation and
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oxidative stress will be monitored to observe the potential increases and/or decreases of these
levels throughout the study. Inflammation will be monitored using enzyme-linked immunosorbent
assay. In this assay, levels of the NLRP3 inflammasome will be monitored, as well as cytokines
IL-1β and IL-18. For oxidative stress, a urinary assay will be used to monitor the levels of nitric
oxide as well as the antioxidant system in the body that works to deplete them.

5.2 Specific Aim One
The first aim of the study is to determine if the ketogenic diet can prevent the onset of OA in NFL
athletes. For the first aim, 24 mice will be used. 12 of the mice will be used in the test group while
the other 12 will be used in the control group. The test group will be fed the KD that is described
above for 3 weeks. During this time, the blood levels will be determined after each meal to ensure
the optimal level is achieved. The blood ketone levels should reach their optimal levels within the
first 3 days, but the full 3 weeks will allow the mice to adapt adequately to the metabolic changes
that occur during ketogenesis. The control group will be fed a regular chow diet but every other
variable will remain the same for the control.

Following the 3 weeks, both the test and control group will undergo OA induction via the Intron
Electro Pulse E1000. In the following weeks, both the inflammation and ROS will be tested using
the analysis outlined above. These results will be monitored and recorded for 5 months following
the induction. Once completed, the animals will be sacrificed in order to compare histological
findings in the knees of both the control and test group. Analysis of the knee joint will include
observation of any potential chondrocyte apoptosis, osteophyte formation, joint space width, and
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cartilage degradation. With these parameters, the study will be able to determine if the ketogenic
diet prevented the induction of OA as compared to the control group.

5.3 Specific Aim Two
The second aim of the study is to determine if the ketogenic diet could be used to treat OA once
degradation has begun. This will require two groups as well, one test and one control. 24 mice will
be used with 12 in each group. For this aim, the mice in both groups will undergo OA induction
via the Intron Electro Pulse E1000 first. Following induction, both the inflammation and ROS will
be tested daily using the analysis outlined above. This will provide a baseline level for both
components in order to compare future data. OA progression will be monitored and once the
disease has shown degradation signs, the test group will be fed a KD. The control group will be
fed a regular chow diet. Again, the blood ketone levels will be monitored for the test group to
ensure the mice stay within the ketosis range. During this time, inflammation and ROS species
will continue to be monitored in order to see any increases or decreases in the levels. The mice
will be continuously monitored for 5 months following the introduction of the KD. At the
completion of the study, the animals will be sacrificed in order to compare histological findings in
the knees of both the control and test group. The knee joint will be analyzed and the parameters
such as chondrocyte apoptosis, osteophyte formation, joint space width, and cartilage degradation
will be observed. With these parameters, the study will be able to determine if the KD treated the
developed OA as compared to the control group.
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5.4 Experimental Pitfalls and Future Aims
These experimental designs are intended to determine if there is a potential for using the ketogenic
diet in NFL athletics. This is the first step to an alternative option for either preventing or treating
a disease that is pervasive amongst these professional athletes. Although this research may shed
some light on unanswered questions, there are some pitfalls that this research cannot overcome.
First, the mice model used in this research is one that does not directly correlate to NFL athletes.
The risk factors that are prevalent amongst NFL athletes are multidimensional with no perfectly
clear path. The research attributes OA development to many factors in NFL athletes such as
weight, joint loading, injuries, knee positioning, biomechanics, and much more. With that being
said, a universal model for OA development in NFL athletes is next to impossible to create. That
is why this research serves to be a starting point for further research. Additionally, research is
inconclusive on how exactly ROS and inflammation are associated with OA. There is some
research to suggest that inflammation and ROS produce the initial insult while other research
suggests that they only potentiate it once it has begun. It may also be a combination of both or
varying in different cases. That being said, this model cannot answer that question specifically but
can only provide experimental outcomes for both cases. Lastly, the KD itself still has much
research that needs to be completed. Currently, research studies have been unable to determine
how the KD, and ketone bodies specifically, work to produce the results that are so often seen with
individuals on the diet. It is not clear whether they work to competitively bind, increase
transcription, or something completely different. This research design does not seek to answer the
question of how it works but only if it may work in this specific population.
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There is still so much research to be had on this topic. OA is a very prevalent disease in the NFL
population but with many outstanding questions to be answered. In the future, this research study
should be use as a launching point for more studies targeting high-risk populations. As stated
above, the mice model does not adequately represent the multidimensional factors of OA
progression in NFL athletes. With that being said, this study should be completed in NFL athletes
themselves to determine if the KD can actually provide a benefit to these professional athletes.
Likewise, a similar study should be carried out to various mice models to determine if there is a
potential for using the diet in other high-risk populations.
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6. Conclusion
Osteoarthritis is a debilitating joint disease that greatly affects so many. It is currently the most
prevalent type of joint disease and the third most rapidly increasing disease associated with
disability.4 Individuals diagnosed with OA are greatly affected in every part of their lives as
activity levels likely decrease because of the pain and inflammation associated with the disease.
Although the disease is a localized to the joint, the diagnosed individual is likely to be affected
holistically as research suggests that 1 in 3 patients over the age of 45 will suffer from depression
or anxiety.6 Other research has even suggested that there is a 55% increase in mortality associated
with the disease.5 These outcomes are quite alarming with no clear end in sight. Treatment
currently consists of NSAIDs or eventual joint replacement. NSAIDs only provide pain relief and
joint replacements are extremely costly and provide a burden on the individual. There needs to be
a better way for those so greatly affected by the disease.

Treatment needs to improved universally but especially for those that are known to be at a high
risk for developing the disease. High-risk groups may include the elderly population or individuals
with occupations that produce strain on the joint. Athletes are one population that are greatly
affected, specifically those that participate in athletics that involve running, jumping, weightlifting, or wrestling. Football involves many of these activities and has continually shown to put
an athlete at high-risk for developing OA. The risk is even higher for football athletes that
participate for long periods of time and extend their participation through professional football in
the NFL. Research showed that 40.6% of 2,538 retired NFL athletes under the age of 60 had been
diagnosed with some form of arthritis.57 This high risk for OA in NFL athletes cannot be
pinpointed to one direct cause but is believed to be a variety of factors that may include joint
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loading, weight, and injury prevalence. Due to the lack of treatment or preventative measures, OA
continues to be a result of pursuing football at the highest level. NFL football continues to be a
beloved sport in the United States, so there needs to be a way to counteract this prevalent OA
development.

After researching the ketogenic diet, it was determined that it could be an option for treating or
preventing OA in NFL athletes. Research shows that oxidative stress and inflammation is greatly
associated with OA. It is currently not known whether these two factors start the production of OA
or if another insult, such as a knee ligament injury, starts the development of OA and ROS and
inflammation are a way that the body responds and subsequently potentiates OA. In any case, the
KD is also associated with a decrease in ROS and inflammation. The high fat, low carb diet
produces ketone bodies that are later used for energy in the body. It is the production of those
ketone bodies and their circulation through the blood that positive effects ensue. It is currently not
known how these ketone bodies produce their results but research has discussed some theories for
their mechanism. Some research suggests that the ketone bodies competitively bind and inhibit the
NLRP3 inflammasome which prevents rapid, uncontrollably inflammation production. Other
research suggests that ketone bodies bind to GPR109A which later inhibits proinflammatory NFκB. Ketone bodies also work to decrease ROS by activating Nrf2 for antioxidants or by inhibiting
HDAC so that transcription of antioxidant molecules may be increased.

The research that is currently available on topics of OA, NFL athletes, and the KD is inconclusive
in many ways. That is the downfall of this research. There are so many questions left unanswered.
This research was only a literature review, so no new answers could be provided, but only a

47
summation of what is currently being discussed in research. With this in mind, research must
progress. OA is a costly and burdensome disease that affects so many. Research needs to progress
in order to provide the answers necessary to find more and better treatment and preventative
measure options. Additionally, the KD has the potential for treating so many diseases, and maybe
that is the downfall for research on this diet. There is so much research being conducted on how
the KD can be used for treatment in Parkinson’s, Alzheimer’s, concussions, cancer, etc. that OA
may be overlooked as a disease it can benefit. In any case, research needs to progress in
determining how the KD works to create these positive outcomes. This will help progress the use
of the diet in multiple diseases. Lastly, there needs to be more focused research on the prevalence
of OA in NFL athletes. OA is rampant amongst retirees of the sport. This is a sad reality for so
many that are pursuing a dream that they have worked so hard to achieve. OA should not be the
common outcome for them. This literature review and research proposal serves as a starting point
for more focused research. If the proposal were to be conducted, the results would provide
interesting information for how research on OA in NFL athletes may proceed.
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